ABCC1 and non-small cell lung carcinoma: For example, circRNA-circ_0076305 has been demonstrated to promote resistance to cisplatin (DDP) in non-small cell lung cancer (NSCLC) by regulating ABCC1 through miR-186-5p, thereby reducing the efficacy of the drug in NSCLC treatment [8].